CARBAMAZEPINE OVERDOSE - THE EFFECTS OF MULTIPLE DOSE ACTIVATED-CHARCOAL

被引:18
作者
WASON, S
BAKER, RC
CAROLAN, P
SEIGEL, R
DRUCKENBROD, RW
机构
[1] UNIV CINCINNATI,COLL MED,CHILDRENS HOSP,MED CTR,CINCINNATI,OH 45221
[2] UNIV CINCINNATI,COLL PHARM,CINCINNATI,OH 45221
来源
JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY | 1992年 / 30卷 / 01期
关键词
CARBAMAZEPINE; POISONING; CHARCOAL; ACTIVATED;
D O I
10.3109/15563659208994444
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
We studied five children with carbamazepine overdose. Two patients had acute overdose without previous exposure to carbamazepine while three presented with acute-on-chronic overdose. Multiple doses of activated charcoal were administered to four patients. One acute-on-chronic patient did not receive any activated charcoal. The mean half-life of carbamazepine was as follows: a) Acute vs. Acute-On-Chronic overdose: 8.63 h vs. 12.01 h (p < 0.05); b) No Activated Charcoal vs. 30-50 g Activated Charcoal vs. 60-90 g Activated Charcoal: 23.3 h vs. 10.17 h vs. 7.21 h (p < 0.05); c) No Activated Charcoal vs. 2-3 doses vs. 7-12 doses: 23.3 h vs. 8.96 h vs 7.55 h (ns). Although the half-life of carbamazepine decreased in a linear relationship with the total amount of activated charcoal administered (r = -0.86), there was no relationship between the time to complete recovery and administration of multiple doses of activated charcoal. Although multiple doses of activated charcoal increased the clearance of carbamazepine in our patients with overdose, it was not associated with clinical benefits.
引用
收藏
页码:39 / 48
页数:10
相关论文
共 11 条
[1]   CLINICAL PHARMACOKINETICS OF CARBAMAZEPINE [J].
BERTILSSON, L .
CLINICAL PHARMACOKINETICS, 1978, 3 (02) :128-143
[2]  
COUTSELINIS A, 1980, J TOXICOL-CLIN TOXIC, V16, P385
[3]   CARBAMAZEPINE TOXICITY - COMPARISON OF MEASUREMENT OF DRUG LEVELS BY HPLC AND EMIT AND MODEL OF CARBAMAZEPINE KINECTICS [J].
DENG, JF ;
SHIPE, JR ;
ROGOL, AD ;
DONOWITZ, L ;
SPYKER, DA .
JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY, 1986, 24 (04) :281-294
[4]   UNUSUAL CASE OF CARBAMAZEPINE POISONING WITH A NEAR-FATAL RELAPSE AFTER 2 DAYS [J].
DEZEEUW, RA ;
WESTENBERG, HGM ;
VANDERKLEIJN, E ;
GIMBRERE, JSF .
CLINICAL TOXICOLOGY, 1979, 14 (03) :263-269
[5]  
HARSCH HH, 1986, NEW ENGL J MED, V314, P318
[6]   EFFECT OF ACTIVATED-CHARCOAL ON ABSORPTION AND ELIMINATION OF PHENOBARBITONE, CARBAMAZEPINE AND PHENYLBUTAZONE IN MAN [J].
NEUVONEN, PJ ;
ELONEN, E .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 17 (01) :51-57
[7]   ASPIRATION OF ACTIVATED-CHARCOAL AND GASTRIC CONTENTS [J].
POLLACK, MM ;
DUNBAR, BS ;
HOLBROOK, PR ;
FIELDS, AI .
ANNALS OF EMERGENCY MEDICINE, 1981, 10 (10) :528-529
[8]   RANDOMIZED STUDY OF THE TREATMENT OF PHENOBARBITAL OVERDOSE WITH REPEATED DOSES OF ACTIVATED-CHARCOAL [J].
POND, SM ;
OLSON, KR ;
OSTERLOH, JD ;
TONG, TG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1984, 251 (23) :3104-3108
[9]  
RITSCHEL WA, 1986, HDB BASIC PHARMACOKI, P443
[10]   ACUTE CARBAMAZEPINE TOXICITY RESULTING FROM OVERDOSE [J].
SULLIVAN, JB ;
RUMACK, BH ;
PETERSON, RG .
NEUROLOGY, 1981, 31 (05) :621-624